Third-Party Literature Enforcement Clarified In FDA Field Personnel Guide
This article was originally published in The Tan Sheet
Executive Summary
Dietary supplement third-party literature displayed in a physically separate location from the respective product is not to be deemed labeling by FDA field personnel even if the publications are "false or misleading, they reference a particular manufacturer or brand of dietary supplements, or they do not present a balanced view of the scientific information on a dietary supplement," FDA advises in a revised Compliance Policy Guide.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning